These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 34238152)
1. KIAA0101 in Malignant Pleural Mesothelioma: A Potential Diagnostic and Prognostic Marker. Lin P; Zhao Y; Li X; Liang Z Comb Chem High Throughput Screen; 2022; 25(9):1498-1506. PubMed ID: 34238152 [TBL] [Abstract][Full Text] [Related]
2. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis. Zhang X; Yang L; Chen W; Kong M Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291 [TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance and immune cell infiltration analysis of differentially expressed genes in malignant pleural mesothelioma]. Wang N; Zhao QN; Yuan Q; Zhu BL; Wu W Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Sep; 41(9):641-647. PubMed ID: 37805421 [No Abstract] [Full Text] [Related]
4. Identification of glycolysis genes signature for predicting prognosis in malignant pleural mesothelioma by bioinformatics and machine learning. Xiao Y; Huang W; Zhang L; Wang H Front Endocrinol (Lausanne); 2022; 13():1056152. PubMed ID: 36523602 [TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of SETD2 in maligant pleural mesothelioma]. Yu M; Yu M; Zhu LJ; Yuan XY; Zhang X Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Feb; 39(2):91-98. PubMed ID: 33691361 [No Abstract] [Full Text] [Related]
6. [Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma]. Mei W; Wang XM; Liu RA; Xiong W; Zhang YP Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Apr; 42(4):258-267. PubMed ID: 38677988 [No Abstract] [Full Text] [Related]
7. Computational genomic analysis of PARK7 interactome reveals high BBS1 gene expression as a prognostic factor favoring survival in malignant pleural mesothelioma. Vavougios GD; Solenov EI; Hatzoglou C; Baturina GS; Katkova LE; Molyvdas PA; Gourgoulianis KI; Zarogiannis SG Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(7):L677-86. PubMed ID: 26254420 [TBL] [Abstract][Full Text] [Related]
8. Identification of genes and pathways involved in malignant pleural mesothelioma using bioinformatics methods. Liu X; Qian K; Lu G; Chen P; Zhang Y BMC Med Genomics; 2021 Apr; 14(1):104. PubMed ID: 33849532 [TBL] [Abstract][Full Text] [Related]
9. Four Immune-Related Genes (FN1, UGCG, CHPF2 and THBS2) as Potential Diagnostic and Prognostic Biomarkers for Carbon Nanotube-Induced Mesothelioma. Xie D; Hu J; Wu T; Cao K; Luo X Int J Gen Med; 2021; 14():4987-5003. PubMed ID: 34511983 [TBL] [Abstract][Full Text] [Related]
10. LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study. Arimura K; Hiroshima K; Nagashima Y; Nakazawa T; Ogihara A; Orimo M; Sato Y; Katsura H; Kanzaki M; Kondo M; Tagaya E BMC Cancer; 2023 Dec; 23(1):1206. PubMed ID: 38062416 [TBL] [Abstract][Full Text] [Related]
11. UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma. Reardon ES; Shukla V; Xi S; Gara SK; Liu Y; Straughan D; Zhang M; Hong JA; Payabyab EC; Kumari A; Richards WG; De Rienzo A; Hassan R; Miettinen M; Xi L; Raffeld M; Uechi LT; Li X; Wang R; Chen H; Hoang CD; Bueno R; Schrump DS J Thorac Oncol; 2021 Jan; 16(1):89-103. PubMed ID: 32927122 [TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer. Shi H; Xu H; Chai C; Qin Z; Zhou W J Clin Lab Anal; 2022 May; 36(5):e24381. PubMed ID: 35403252 [TBL] [Abstract][Full Text] [Related]
13. Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients. Bai Y; Wang X; Hou J; Geng L; Liang X; Ruan Z; Guo H; Nan K; Jiang L Front Genet; 2020; 11():899. PubMed ID: 32849853 [TBL] [Abstract][Full Text] [Related]
14. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis. Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011 [TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of COL1A1 and COL1A2 genes in malignant pleural mesothelioma tissues]. Li B; Pu YQ; Li ZL; Zhao Y; Zi JJ; Xiong W Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Jul; 40(7):487-494. PubMed ID: 35915937 [No Abstract] [Full Text] [Related]
16. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer. Zhou M; Chen Y; Gu X; Wang C Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144 [No Abstract] [Full Text] [Related]
19. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis. Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030 [TBL] [Abstract][Full Text] [Related]